ABSTRACT: This study explored the hypothesis that mannan oligosaccharide (MOS) acts to reduce systemic inflammation in pigs by evaluating cytokine production of alveolar macrophages (AM) and serum cytokine concentrations. A total of 160 pigs were fed diets containing 0.2 or 0.4% MOS for 2 or 4 wk postweaning compared with control diets without MOS. Dietary MOS did not affect the serum concentration of tumor necrosis factor (TNF)-α and tended (P = 0.081) to increase that of IL-10. These cytokine concentrations also changed over time (P < 0.001). After 2-wk feeding of the control or MOS diets, AM were collected and stimulated ex vivo with lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (PLIC) as infection models. The LPS-stimulated AM from MOS-fed pigs (n = 12) secreted less TNF-α (P < 0.001) and more IL-10 (P = 0.026) than those from control-fed pigs (n = 6). However, dietary MOS had less effect on ex vivo TNF-α and IL-10 production by PLIC-stimulated AM (P = 0.091 and P > 0.10, respectively. Further, effects of MOS were examined in 4 in vitro experiments. In Exp. 1 (n = 4 pigs), MOS and mannan-rich fraction (MRF), when added to AM cultures, were able to increase TNF-α production. This direct effect of MOS was not due to endotoxin contamination as verified in Exp. 2 (n = 6 pigs) using polymyxin B, an inhibitor of LPS activation of toll-like receptor 4. Polymyxin B inhibited production of TNF-α by AM after treatment with LPS (P < 0.001), but not after treatment with MOS in the absence of LPS (P > 0.70). In Exp. 3 (n = 6 pigs), when MOS was directly applied in vitro, the pattern of cytokine production by LPS-activated AM was similar to that observed ex vivo, as MOS suppressed LPS-induced TNF-α (P < 0.001) and enhanced LPS-induced IL-10 (P = 0.028). In Exp. 4 (n = 6 pigs), when MRF replaced MOS, AM-produced TNF-α induced by LPS or PLIC was suppressed by MRF (P = 0.015 or P < 0.001, respectively). These data establish that MOS and MRF suppress LPS-induced TNF-α secretions by AM. Generally, the study suggests that MOS may be a potent immunomodulator because it directly activates AM to secrete TNF-α and alters the cytokine responses of bacterial endotoxin-induced AM in both ex vivo and in vitro systems. In particular, feeding MOS to pigs for 2 wk reduces TNF-α and increases IL-10 concentrations after ex vivo treatment of AM with LPS. These immunomodulatory properties of MOS may have important implications for both host defense and avoidance of harmful overstimulation of the immune system.
INTRODUCTION
Mannan oligosaccharide (MOS), derived from the cell wall of yeast Saccharomyces cerevisiae, has been shown to promote growth in young pigs and poultry (Hooge, 2004a,b; Miguel et al., 2004) . The improvement in animal performance may be due in part to the ability of MOS to inhibit attachment of pathogens with type I fimbriae to the intestinal wall of animals (Oyofo et al., 1989a,b; Spring et al., 2000) . The unattached harmful bacteria are taken with digesta to the large intestine and then excreted in feces, resulting in a healthy gut.
Effects of MOS on innate and acquired immunity have also been reported. Mannan oligosaccharide enhanced the phagocytic activity of lamina propria macrophages isolated from nursery pigs (Davis et al., 2004) . Feeding MOS to animals also increased the immunoglobulin concentrations in serum and colostrum (Shashidhara and Devegowda, 2003; Spearman, 2004) . These results show that MOS affects immune function, but specific effects require clarification. In particular, it is important to know the impact of MOS on secretion of cytokines under various conditions. Cytokines that are synthesized by cells of the innate immune system, such as macrophages, not only regulate immune function but also alter many metabolic processes (Johnson, 1997; Elsasser et al., 2008) . Thus, a balance between proinflammatory [e.g., IL-1, IL-6, tumor necrosis factor-α (TNF-α)], and anti-inflammatory (e.g., IL-10) cytokines plays an important role in growth responses and in maintaining appropriate and efficient activity of the immune system in response to surrounding immunological challenges.
The objectives of the study were to evaluate effects of dietary MOS on serum cytokines and growth performance of nursery pigs and to determine whether MOS, when fed to pigs or directly applied in vitro, can modulate cytokine production by alveolar macrophages (AM) stimulated with bacterial or viral challenge models.
MATERIALS AND METHODS
The experimental protocol used in this study was approved by the University of Illinois Institutional Animal Care and Use Committee.
Pig Feeding Experiment
One hundred sixty barrows and gilts (20 d old; 6.5 ± 1.1 kg of BW) from Pig Improvement Company (PIC) line C-22 females mated to PIC line 337 boars were blocked by initial BW and randomly allotted to 5 treatments in a randomized complete block design ( Figure  1 ). Each pen within a block had 2 barrows and 2 gilts. Ancestry was equalized across treatments as much as possible. Immediately upon entering the nursery facility after weaning (d 0), pigs were fed the 5 experimental diets: 0% MOS supplementation as the control diet (diet 1), 0.2% MOS through d 14 (diet 2) or d 28 (diet 3), 0.4% MOS through d 14 (diet 4) or d 28 (diet 5) postweaning (PW). Mannan oligosaccharide was provided by Alltech Inc. (Nicholasville, KY). There were 8 replicate pens per treatment and 4 pigs per pen. Pigs were housed in an environmentally controlled nursery and had ad libitum access to feed and water at all times. Each pen measured 1.32 × 1.32 m in size with metal-slatted floor and had one nipple waterer. Pigs were fed the basal diets (Table 1) formulated to contain quantities of all the essential nutrients that met or exceeded the nutritional requirements of pigs during the nursery period (NRC, 1998) .
The BW of each pig was recorded at weaning (d 0) and on d 7, 14, 21, and 28 PW. Feed disappearance was measured each week, for calculation of ADG, ADFI, and G:F for each pen.
At 14 d PW, the lighter barrow from each pen of 6 blocks (6 pigs per treatment) was euthanized for collection of AM (Figure 1 ). The AM collected were then stimulated ex vivo with lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (PLIC) as described below, and concentrations of TNF-α and IL-10 in the supernatants were measured.
Blood Collection and Processing
Blood samples were collected at d 0, 7, 14, 21, and 28 after the commencement of the experiment. The heavier barrow in each replicate pen (8 pigs per treatment) was selected at d 0 for blood collection, and blood samples were repeatedly taken from the same pigs throughout the experiment. Ten milliliters of blood from each pig were collected into Vacutainer glass tubes containing no anticoagulant. Blood was allowed to clot at room temperature for 45 min and stored overnight at 4°C before harvest of serum by centrifugation (1,800 × g, 10 min, room temperature). The collected serum was aliquoted and frozen at −80°C, and later analyzed for TNF-α and IL-10 by ELISA kits as described below.
Collection and Isolation of Alveolar Macrophages
Pigs were anesthetized by intramuscular injection of a 1-mL combination of telazol, ketamine, and xylazine (2:1:1) per 23.3 kg of BW. The final mixture contained 100 mg of telazol, 50 mg of ketamine, and 50 mg of xylazine in 1 mL (Fort Dodge Animal Health, Fort Dodge, IA). After anesthesia, pigs were euthanized by intracardiac injection with 78 mg of sodium pentobarbital (Sleepaway) per 1 kg of BW (Henry Schein Inc., Indianapolis, IN). Alveolar macrophages were collected by pulmonary lavage with 150 mL of PBS without Ca and Mg (Hyclone Laboratories Inc., Logan, UT). Lavage fluid was filtered through a double layer of sterile gauze and then centrifuged at 400 × g for 15 min at room temperature. After centrifugation, lung lavage cells were washed twice with Hank's balanced salt solution (Hyclone Laboratories Inc.) and resuspended in 5 mL of RPMI 1640 culture medium (Hyclone Laboratories Inc.) containing 10% heat-inactivated fetal bovine serum (Hyclone Laboratories Inc.), penicillin (100 IU/mL; Mediatech Inc., Manassas, VA), and streptomycin (100 µg/mL; Mediatech Inc.). The percentage of live cells was determined by Trypan Blue dye exclusion (Sigma-Aldrich Co., St. Louis, MO), and the cells were adjusted to 1 × 10 6 cells/mL. The cell viability was >97%. The percentages of macrophages in bronchoalveolar lavage cell populations as routinely determined by our laboratory and other researchers (Shibata et al., 1997; Dickie et al., 2009 ) range from 88 to 95% and 93 to 97.5%, respectively.
Culture and Stimulation of AM
Alveolar macrophages were cultured in 96-well plastic tissue culture plates at a density of 1 × 10 5 cells per well and incubated overnight at 37°C in a humidified 5% CO 2 incubator to allow AM to adhere to the plates. The plates were washed 3 times with warm Hank's balanced salt solution to remove nonadherent cells. The adhered AM were treated in triplicates with 200 µL of culture media containing several substances including yeast cell wall components [MOS, glucan fraction (GLUF), mannan-rich fraction (MRF)] and infection models (LPS, PLIC). The stimulated AM were then incubated for 24 h more before the collection of supernatants, which were aliquoted and frozen at −80°C until measurement of TNF-α and IL-10 concentrations.
Irradiated MOS, GLUF, and MRF were obtained from Alltech Inc. The GLUF and MRF were also extracted from the yeast cell wall, but contained more β-glucan and mannose, respectively, than MOS. The sugar profile of the yeast components was measured according to methods described previously (Kiho et al., 1986; Kakehi and Honda, 1989; AOAC, 1990 ) and is presented in Table 2 . The LPS and PLIC, purchased from Sigma-Aldrich Co., have been widely used as models to imitate the acute phase responses to bacterial and viral infections, respectively (Huang et al., 2006; Loving et al., 2006) .
Tests of Ex Vivo Cytokine Secretion by Stimulated AM After MOS Feeding
Effects of different dietary quantity of MOS on ex vivo secretion of cytokines by AM in response to infection models were tested (Figure 1 ). Treatments 2 and 3 were treated identically until d 14 PW, so data from pigs in these treatments were pooled to represent the 0.2% MOS treatment. Similarly, data from pigs in treatments 4 and 5 were pooled to represent the 0.4% MOS treatment. The AM from pigs fed 0% (control, n = 6), 0.2% (n = 12), or 0.4% (n = 12) MOS were stimulated ex vivo with LPS (1 µg/mL) or PLIC (50 µg/mL). The concentrations of LPS and PLIC used were predetermined in an experiment using AM stimulated with varying concentrations of LPS or PLIC. The TNF-α response of AM to those stimulators peaked at 1 µg/mL of LPS and 50 µg/mL of PLIC.
Tests of Activity of Yeast Components In Vitro
Four experiments were conducted to test in vitro effects of yeast components on cytokine production by (1), 0.2% MOS fed for 2 wk followed by control diet (2), 0.2% MOS fed for 4 wk (3), 0.4% MOS fed for 2 wk followed by control diet (4), and 0.4% MOS for 4 wk (5). In the ex vivo experiment, after 2-wk feeding of the above experimental diets, alveolar macrophages (AM) from pigs fed control (n = 6), 0.2% MOS (n = 12), and 0.4% MOS (n = 12) were collected and then stimulated ex vivo with lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (PLIC). There were 4 in vitro experiments in which untreated generic pigs were used as AM donors and had age and weight similar to pigs in the ex vivo experiment. There were 4 replicate pigs in Exp. 1 and 6 replicate pigs each in Exp. 2, 3, and 4. Abbreviations: glucan fraction (GLUF), mannan-rich fraction (MRF), polymyxin B (PMB). AM ( Figure 1 ). The AM for these experiments were collected from untreated generic donor pigs, where the pig was the replicate. Each experiment had 6 untreated donor male pigs (5 to 6 wk old), except that Exp. 1 had 4 replicate pigs. In Exp. 1, AM were activated with increasing concentrations of MOS, GLUF, or MRF, varying from 0 to 3 mg/mL. The concentration of yeast components selected for use in this study ranged from 0 to 3 mg/mL because it was reported that MRF at 2.5 mg/mL was the optimal concentration, not being toxic to macrophages, but stimulating cell proliferation (Singboottra, 2005) . The concentration at which the greatest TNF-α concentration was determined was used in subsequent experiments. In addition, the concentrations of LPS and PLIC described earlier were also used in the following experiments. In Exp. 2, to learn whether the effect of MOS is not due to endotoxin contamination, AM (n = 6 pigs) were cultured in vitro in the absence (0 µg/mL) or presence (30 µg/mL) of polymyxin B (PMB, an anti-inflammatory agent) for 30 min, and then stimulated with control (medium), MOS, GLUF, or LPS. The concentration of PMB used was predetermined to significantly inhibit LPS-induced TNF-α. Briefly, AM were stimulated with LPS in the presence of increasing concentrations of PMB (0, 10, 20, 30, 40, 50 , and 60 µg/mL). Tumor necrosis factor-α production was substantially inhibited at a concentration equal to or greater than 30 µg/mL of PMB. In Exp. 3, AM from 6 donor pigs were stimulated with control (medium), LPS, or PLIC in the absence or presence of MOS. The AM were preincubated with control or MOS for 30 min before the medium, LPS, or PLIC were added into the cultures to stimulate AM. Experiment 4 was identical to Exp. 3 but used MRF instead of MOS.
Measurement of Cytokines
Tumor necrosis factor-α and IL-10 concentrations in serum and in supernatants from AM incubations were measured in duplicate by ELISA kits specific for porcine TNF-α and IL-10 (R & D Systems, Minneapolis, MN). Standards of known recombinant porcine TNF-α and IL-10 concentration were used. The minimum detectable dose of porcine TNF-α by the assay was 3.7 pg/mL. The intra-and interassay CV were <6.9% (6.2% for supernatant) and <9.2% (10% for supernatant), respectively. The minimum detectable dose of porcine IL-10 by the assay was 3.5 pg/mL. The intra- and interassay CV were <4.2 and <7.2%, respectively. The results were expressed in picograms per milliliter based on a standard curve.
Statistical Analyses
Data were analyzed by ANOVA using the MIXED procedure (SAS Inst. Inc., Cary, NC). For the pig feeding experiment, data were analyzed as a randomized complete block design with pen as the experimental unit. For performance data and ex vivo cytokine concentrations in supernatants, the model included the effect of dietary treatment. Serum cytokines were analyzed as repeated measures over time and the model included the effects of dietary treatment, day, and interaction of dietary treatment × day. For in vitro Exp. 1, 2, 3, and 4, donor pigs were considered blocks and a pool of 3 wells was considered an experimental unit. For Exp. 1, the model included the effect of concentration of yeast components. For Exp. 2, the model included the effects of PMB, stimulator, and interaction of PMB × stimulator. For Exp. 3, the model included the effects of MOS, stimulator, and interaction of MOS × stimulator. For Exp. 4, the model included the effects of MRF, stimulator, and interaction of MRF × stimulator. Blocks were considered random effects in all experiments. Treatment differences were compared using the least squares means with a Tukey adjustment. Treatment effects were considered significant at P < 0.05, whereas a trend for a treatment effect was noted when P < 0.10.
RESULTS

Growth Performance and Serum Cytokines in Response to Different Dietary Quantities of MOS
Supplementation of MOS had no effect on ADG, ADFI, and G:F during d 0 to 14 and d 14 to 28 PW, or over the entire experiment (P > 0.30; data not shown). There were no effects of dietary MOS on the serum TNF-α concentration throughout the experiment (P > 0.70; Figure 2A ). Feeding MOS tended to increase the serum IL-10 concentration (P = 0.081; Figure 2B ). The diet × day interaction did not affect serum concentrations of TNF-α and IL-10 (P > 0.80). However, there was a significant effect of day on serum TNF-α and IL-10 concentrations (P < 0.001). The TNF-α concentrations at d 0, 7, and 28 PW were much greater than those at d 14 and 21 PW (P < 0.001). There were no differences in the serum TNF-α concentration among d 0, 7, and 28 PW or between d 14 and 21 PW (P > 0.60). The serum IL-10 concentrations at d 14 and 28 PW were significantly greater than those at d 0, 7, and 21 PW (P < 0.001). There were no differences in serum IL-10 concentrations between d 14 and 28 PW or among d 0, 7, and 21 PW (P > 0.20).
Ex Vivo Cytokine Secretion by AM After MOS Feeding
The AM from pigs fed 0.2% (303 ± 22.4 pg/mL) or 0.4% (250 ± 22.4 pg/mL) MOS produced less TNF-α (P < 0.001), in response to LPS stimulation, than those from pigs fed the control diet (577 ± 31.7 pg/mL; Figure 3A ). There were no differences in AM-produced TNF-α between 0.2% and 0.4% MOS diets (P = 0.105). The LPS-stimulated AM from MOS-fed pigs (27 ± 2.0 pg/mL) secreted more IL-10 (P = 0.026) than those from control-fed pigs (21 ± 1.4 pg/mL; Figure 3B ), but there were no differences in AM-produced IL-10 between 0.2% and 0.4% MOS diets (P > 0.90). Unlike the response to LPS stimulation, the comparison of TNF-α produced by PLIC-induced AM from pigs fed 0.2% (746 ± 33.2 pg/mL) or 0.4% (708 ± 33.2 pg/mL) MOS to that of pigs fed the control diet (839 ± 46.9 pg/mL) tended to be significant (P = 0.091; Figure  3C ). There were no effects of different dietary MOS on IL-10 secretion by PLIC-stimulated AM (P = 0.176; Figure 3D ).
Direct Cytokine Production with In Vitro Stimulation of Different Yeast Components
All 3 yeast components tested increased (P < 0.01) TNF-α production by AM, but the patterns of response differed (Figure 4) . The TNF-α production was greatest (458 ± 48.6 pg/mL) at 0.5 mg/mL of MOS and decreased as dietary MOS increased. The TNF-α response to GLUF stimulation appeared to be similar to but slightly weaker than the TNF-α response to MOS stimulation, with a peak of 376 ± 34.7 pg/mL at a GLUF concentration of 0.5 mg/mL. When activated by MRF, a greater concentration of MRF (2.5 mg/mL) was required to maximize TNF-α production (164 ± 27.0 pg/mL).
Polymyxin B Inhibited TNF-α Induced by LPS, But Not by MOS
To learn if the effect of MOS on TNF-α production by AM is not due to endotoxin contamination, PMB (30 µg/mL) was added to cultures. The PMB is a potent antibiotic that binds to endotoxins such as LPS and neutralizes their pro-inflammatory effect. The TNF-α production of AM induced by GLUF (0.5 mg/mL) or LPS (1 µg/mL) was substantially inhibited (>95.0%) by PMB treatment (P < 0.001; Figure 5 ). In contrast, TNF-α production induced by MOS (0.5 mg/ mL) in the presence of PMB was reduced by only 4.2%. This result indicates that the stimulation of AM by MOS was not due to contamination with an endotoxin such as LPS because PMB inhibited the effects of LPS but not those of MOS. Also, activation of AM by MOS differed from activation by GLUF.
In Vitro Modulation of LPS-or PLICInduced Cytokine Production by MOS and MRF
In the experiment with MOS, both infection models increased TNF-α production by AM compared with the control (P < 0.001; Figure 6A ). The TNF-α response to PLIC (1,133 ± 39.3 pg/mL) was much greater (P < 0.001) than that to LPS (606 ± 39.3 pg/mL). In cultures stimulated with LPS, MOS reduced TNF-α (711 vs. 502 ± 55.6 pg/mL; P = 0.014). However, MOS did not alter TNF-α in the presence of PLIC (P > 0.30), and increased TNF-α (P < 0.01) compared with the control (no LPS or PLIC). This pattern of response resulted in an interaction between MOS and infection models (P < 0.001). Conversely, MOS increased (31 vs. 23 ± 2.5 pg/mL; P = 0.028) LPS-induced IL-10 compared with LPS alone, but did not alter IL-10 production in the presence of PLIC or in the absence of infection models (P > 0.70), again resulting in an interaction between MOS and infection models (P = 0.023; Figure 6B ).
In the experiment with MRF, both infection models increased TNF-α production by AM compared with the control (P < 0.001; Figure 7A ). The TNF-α response to PLIC (849 ± 21.4 pg/mL) was much greater (P < 0.001) than that to LPS (464 ± 21.4 pg/mL). Like MOS, MRF reduced LPS-stimulated TNF-α (411 vs. 517 ± 29.4 pg/mL; P = 0.015). Unlike MOS, MRF reduced PLIC-stimulated TNF-α to a greater extent (721 vs. 977 ± 29.4 pg/mL; P < 0.001). It did not affect TNF-α in the absence of infection models (P > 0.90), and there was an overall interaction (P < 0.01) between MRF and infection models. Neither MRF nor infection models altered IL-10 production of AM (P > 0.20; Figure 7B ). . Supplementation of MOS did not affect the TNF-α concentrations (P > 0.70) and tended to increase the IL-10 concentrations (P = 0.081). The TNF-α concentrations at d 0, 7, and 28 PW were greater than those at d 14 and 21 PW (P < 0.001). The IL-10 concentrations at d 14 and 28 PW were greater than those at d 0, 7, and 21 PW (P < 0.001). There were no interactions between MOS and day on the TNF-α and IL-10 concentrations (P > 0.80). Data were means ± pooled SEM; 8 pigs per treatment.
DISCUSSION
Previous studies have shown that MOS increases phagocytic activity of porcine macrophages and humoral immunity in chickens (Shashidhara and Devegowda, 2003; Davis et al., 2004) . These data suggest that MOS may have direct effects on cytokine secretions of phagocytes/monocytes. Understanding MOS effects on cytokine production by AM is important to us because our follow-up study will examine MOS effects on immune responses in pigs infected with the porcine reproductive and respiratory syndrome virus, which targets AM.
In the present study, we demonstrated that MOS was a potent immunomodulator under various conditions without compromising pig performance.
Addition of MOS to diets in this study showed no influence on growth performance of nursery pigs, although a large body of data indicates that MOS increases growth rate (Miguel et al., 2004) . Growth performance responses to MOS supplementation are variable, being especially related to growth rate of pigs (Miguel et al., 2004) . The meta-analysis of Miguel et al. (2004) suggests that MOS produces little or no response in pigs with increased growth rate (>180 g/d) during the first Figure 3 . Supernatant cytokine production by alveolar macrophages (AM) from pigs fed diets with 0, 0.2, and 0.4% mannan oligosaccharide (MOS) supplementation for 2 wk in response to ex vivo lipopolysaccharide (LPS, 1 µg/mL) or polyinosinic:polycytidylic acid (PLIC, 50 µg/mL). A and B) LPS-stimulated AM from pigs (n = 12) fed MOS diets, regardless of inclusion levels, produced significantly less (P < 0.001) tumor necrosis factor (TNF)-α and more IL-10 (P = 0.026) than those from pigs (n = 6) fed the control diet. C) The PLIC-stimulated AM from pigs fed MOS diets, regardless of inclusion levels, tended to produce less TNF-α (P = 0.091) than those from pigs fed the control diet. D) There were no effects of dietary MOS on IL-10 production by PLIC-stimulated AM (P = 0.176). Data were means ± pooled SEM.
1 to 2 wk PW. The increased growth rate of weaned pigs (>280 g/d) in the present study may explain why no effect of MOS on growth was detected.
Although effects of MOS on immune responses in animals have been demonstrated (Shashidhara and Devegowda, 2003; Davis et al., 2004) , little is known about its effect on cytokine production. Cytokines not only regulate the immune response of the body but also affect nutrient metabolism (Johnson, 1997; Spurlock, 1997) . Pro-inflammatory cytokines cause anorexia and redirect nutrients away from growth toward immune defense processes, leading to decreased efficiency of energy and nutrient use (Elsasser et al., 2008) . For instance, during inflammation, muscle protein degradation increases to make AA available for accelerated synthesis of acute phase protein from liver. Feed additives possessing immunomodulatory effects may potentially induce overproduction of cytokines that would compromise animal performance. Therefore, this study used multiple approaches to assess the impacts of MOS on cytokine production.
First, we assessed serum concentrations of TNF-α and IL-10 in association with dietary quantity and feeding time of MOS but without experimentally imposed stimulation of the immune system. There were significant variations in serum concentrations of TNF-α and IL-10 during the course of study. This revealed that pigs exposed to the PW environment had physiologically altered concentrations of inflammatory-mediating cytokines, so secretion of those mediators at a specific time is critical. Activation of the immune system is tightly regulated through several mechanisms to maintain disease resistance and prevent immune-mediated disorders within the host. The greater concentrations of IL-10 after or along with the increased concentrations of TNF-α may highlight the important role of this cytokine in regulation of immune and inflammatory responses. The IL-10 has been shown to suppress TNF-α production and other cytokines and chemokines to maintain the homeostasis of the immune system (Turnbull and Rivier, 1999; Moore et al., 2001) . In the present study, feeding MOS to pigs tended to cause increased concentrations of serum IL-10, which may help prevent overstimulation of the immune system in pigs reared under environments where pathogen pressure is greater. In summary, serum concentrations of TNF-α and IL-10 intermittently increased during the experimental period, but no clear impact of MOS on those cytokines could be substantiated.
Previous studies have shown that MOS may have direct effects on cytokine responses of phagocytes/ monocytes because it increased both phagocytic activity of murine macrophages and acquired immunity in chicken and pigs (Newman, 1995; Shashidhara and Devegowda, 2003; Davis et al., 2004) . In the present study, it was found that MOS, when fed to nursery pigs for 2 wk PW, altered ex vivo cytokine secretion by AM in response to LPS stimulation, but not to PLIC. In particular, the LPS-stimulated AM from MOS-fed pigs produced less TNF-α and more IL-10 than those from pigs fed the control diet. The mechanism for this immune response is unknown, but may be associated with an ability of MOS to modulate cell receptor-induced responses by interacting with the mannose receptors (MR) or other toll-like receptors (TLR). The MOS Figure 4 . Tumor necrosis factor (TNF)-α production by alveolar macrophages (AM) activated with increasing concentrations of mannan oligosaccharide (MOS), glucan fraction (GLUF), or mannan-rich fraction (MRF). All 3 yeast components stimulated TNF-α production by AM (P < 0.001), but with different patterns of response. The TNF-α response of AM peaked at 0.5 mg/mL of MOS, 0.5 mg/mL of GLUF, and 2.5 mg/mL of MRF. Data were means of 4 replicates. **P < 0.01 and ***P < 0.001: different from the control (within a line). The AM were collected from untreated pigs as AM donors used in Exp. 1. Figure 5 . Tumor necrosis factor (TNF)-α production by alveolar macrophages (AM) activated with mannan oligosaccharide (MOS, 0.5 mg/mL), glucan fraction (GLUF, 0.5 mg/mL), or lipopolysaccharide (LPS, 1 µg/mL) in the presence (30 µg/mL) or absence (0 µg/mL) of polymyxin B (PMB). There were effects of stimulator, PMB, and interaction of stimulator × PMB (P < 0.001). Polymyxin B significantly inhibited TNF-α production induced by GLUF or LPS (P < 0.001), but not by MOS (P > 0.70). Data were means ± pooled SEM (n = 6). Means with different letters (a,b) differ (P < 0.001). The AM were collected from untreated pigs as AM donors used in Exp. 2.
contains an increased amount of mannan which can be recognized by MR (Giaimis et al., 1993; Underhill and Ozinsky, 2002) . Mannose receptor activation by MOS can interfere with functions of other cell receptors (e.g., TLR2 or TLR4), leading to reduced production of proinflammatory cytokines and enhanced IL-10 (Gazi and Martinez-Pomares, 2009) . In summary, feeding MOS to nursery pigs suppressed TNF-α and increased IL-10 production after ex vivo treatment of AM with LPS, but the mechanism for the modulated cytokine responses of AM needs further investigation.
Further, the in vitro induction of AM-produced TNF-α by various yeast cell wall components confirmed that MOS has a direct effect on the immune response of AM. The GLUF and MOS can activate AM to secrete TNF-α. The stimulating effect of GLUF is perhaps because GLUF contains an increased amount of β-glucan (66.8%). It was reported that macrophages Figure 6 . Tumor necrosis factor (TNF)-α or IL-10 production by alveolar macrophages (AM) stimulated in vitro with lipopolysaccharide (LPS, 1 µg/mL) or polyinosinic:polycytidylic acid (PLIC, 50 µg/mL) in the absence (0 mg/mL) or presence (0.5 mg/mL) of mannan oligosaccharide (MOS). A) Both infection models increased TNF-α production by AM compared with the control (P < 0.001). There was an interaction of MOS × infection models (P < 0.001) on AM-produced TNF-α. The TNF-α production was less in the presence of MOS than in the absence of MOS when stimulated by LPS (P = 0.014), but not when stimulated by PLIC (P > 0.30). The MOS, in the absence of infection models, increased TNF-α production by AM compared with the control (P < 0.01). B) There was an interaction of MOS × infection models on IL-10 production by AM (P = 0.023). The LPS-induced IL-10 production was greater in the presence of MOS than in the absence of MOS (P = 0.028). In cultures stimulated with PLIC, MOS did not affect IL-10 production (P > 0.70). Data were means ± pooled SEM (n = 6). Means with different letters (a-e) differ (P < 0.05). The AM were collected from untreated pigs as AM donors used in Exp. 3. stimulated with β-glucan produced nitric oxide (NO), interferon-γ, TNF-α, IL-1, and IL-6 (Adachi et al., 1994; Ohno et al., 1996; Tokunaka et al., 2000) . With regard to MOS, activation of AM by MOS in vitro may be associated with both β-glucan (29.9%) and mannan (26.6% as mannose) fractions. The induction of TNF-α by MOS partially supports previous findings that MOS enhances the phagocytic activity of macrophages (Newman, 1995; Davis et al., 2004) . Activated phagocytes secrete cytokines, which in turn upregulate the expression of molecules involved in phagocytosis and digestion of ingested particles or microbes (Moore et al., 2001; Underhill and Ozinsky, 2002) . In contrast to MOS and GLUF, MRF seemed to have a weak induction on TNF-α production by AM. The differences in immunostimulatory characteristics among mannancontaining products may be ascribed to the polymerization degree of mannan (Bland et al., 2004) , types of terminal linkages of mannan sequences (Young et al., 1998) , or source of mannan (Djeraba and Quere, 2000; Sheng et al., 2006) . Collectively, the results of this study suggest that MOS can directly stimulate AM Figure 7 . Tumor necrosis factor (TNF)-α or IL-10 production by alveolar macrophages (AM) stimulated in vitro with lipopolysaccharide (LPS, 1 µg/mL) or polyinosinic:polycytidylic acid (PLIC, 50 µg/mL) in the absence or presence of mannan-rich fraction (MRF, 2.5 mg/mL). A) There were effects of MRF, infection models, and interaction of MRF × infection models on TNF-α secretion by AM (P < 0.01). The MRF significantly suppressed TNF-α production by AM stimulated with either LPS (P = 0.015) or PLIC (P < 0.001). There were no differences in AM-produced TNF-α between MRF and the control in the absence of infection models (P > 0.90). B) There were no effects of MRF, infection models, or their interaction on IL-10 production by AM (P > 0.20). Data were means ± pooled SEM (n = 6). Means with different letters (a-e) differ (P < 0.05). The AM were collected from untreated pigs as AM donors used in Exp. 4. to secrete TNF-α. Also, GLUF, but perhaps not MRF, is a potent immunostimulant of AM.
The immunostimulatory effect of MOS found above was not due to endotoxin contamination and appeared to be different from that of GLUF. This was demonstrated by using PMB, which indirectly inhibits the activation of LPS-mediated TLR4 by binding to endotoxins such as LPS (Stokes et al., 1989; Cardoso et al., 2007; Zavascki et al., 2007) . Polymyxin B significantly inhibited TNF-α production induced by LPS, but not by MOS. If it was assumed that β-glucan in both MOS and GLUF was the only immunostimulatory agent involved in the activation of AM, TNF-α production induced by MOS or GLUF could have been suppressed by PMB. However, lack of inhibitory effects of PMB on MOS-induced TNF-α suggests that molecules apart from β-glucan, presumably mannans, in MOS may play a significant role in stimulating AM to secrete TNF-α. It was reported that β-glucan upregulated the expression of TLR4 and dectin-1 in porcine AM (Chaung et al., 2009) . It is unknown whether PMB inhibits GLUFinduced TNF-α through interacting with β-glucan or with pattern recognition receptors including TLR4 and dectin-1. Thus, further research on this aspect is necessary.
When directly applied in vitro, both MOS and MRF reduced LPS-induced TNF-α, consistent with the effect of feeding MOS in the ex vivo experiment. However, MRF did not appear to greatly induce TNF-α production by AM, but surprisingly suppressed the TNF-α secretion by AM stimulated not only by LPS but also by PLIC. Downregulation of TLR4 and reduced activity of MR could possibly contribute to these inhibitory effects. These receptors, if activated, trigger an intracellular signal transduction cascade, resulting in changes in cytokine synthesis. Singboottra (2005) found that the reduced IL-6 expression in MRF-stimulated chicken macrophages was mediated through a decreased expression of TLR4. Because LPS is a ligand specific for TLR4 (Raetz and Whitfield, 2002) and triggers TNF-α production, this could explain why there was a decreased TNF-α concentration in LPS-stimulated AM in the presence of MOS or MRF. The effect of MRF on PLIC-induced TNF-α is not clearly understood, but appears to be associated with the increased concentration of mannan and the different structure of a complex of mannan and β-glucan in MRF. The binding of PLIC to its specific receptor, TLR3, leads to AM activation (Huang et al., 2006; Loving et al., 2006) ; however, TLR3 is an intracellular receptor, and therefore PLIC needs to be taken up by AM before inducing an inflammatory response through binding to TLR3. The MR, which can recognize mannan, was suggested to be a major endocytic receptor in the infectious entry of viruses into murine macrophages (Tizard et al., 1989; Reading et al., 2000; Davis et al., 2002) . Therefore, it may be speculated that MR ligation by MRF was not significantly responsible for TNF-α release, but it reduced PLIC-induced TNF-α by preventing MR-mediated internalization of PLIC because of downregulated MR expression or reduced endocytic activity of MR. Thus, the amount and structure of mannan in MRF would determine the intensity of inflammation induced by PLIC.
Taken altogether, effects of the tested products on the immune responses of AM may be dependent on how mannan and β-glucan present in those products interact with receptors of AM. The content, type, and structure of constituent carbohydrates of yeast cell wall extracts are important in activating AM through binding to their pattern recognition receptors such as TLR4 and MR. The expression of those receptors, along with the immune activation status of AM, would influence the transmission of a specific signal that results in activation of downstream signaling cascades, and thereby the production of inflammatory mediators. These aspects are beyond the scope of this study and therefore require further investigation.
Generally, feeding MOS did not affect growth performance of nursery pigs under the current experiment. Dietary MOS did not clearly alter the serum concentration s of TNF-α and tended to increase the serum concentrations of IL-10. These serum concentrations of cytokines also changed over time. The ex vivo and in vitro experiments suggest that MOS may be a potent immunomodulator. The ability of MOS to directly induce cytokine secretions by AM has important implications in the physiological mechanisms of host defense against invading bacteria or viruses. Importantly, MOS altered the immune response of bacterial endotoxin-induced AM, reducing TNF-α and enhancing IL-10 synthesis. Therefore, MOS may help prevent overstimulation of the immune system of the host animal after an immunological challenge. Further research, however, should be conducted to determine effects of MOS on immune function and growth performance in pigs challenged in vivo with bacteria or viruses.
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